Exp Mol Med.  2010 Jul;42(7):514-523. 10.3858/emm.2010.42.7.052.

A serum-stable branched dimeric anti-VEGF peptide blocks tumor growth via anti-angiogenic activity

Affiliations
  • 1Department of Life Science, Division of Molecular and Life Sciences, Pohang University of Science and Technology, Pohang 790-784, Korea. ysgho@postech.ac.kr
  • 2Department of Biochemistry, College of Medicine, Chungnam National University, Daejeon 301-130, Korea.
  • 3Department of Biomedical Science and Technology, Institute of Biomedical Science and Technology, Konkuk University, Seoul 143-701, Korea.

Abstract

Angiogenesis is critical and indispensable for tumor progression. Since VEGF is known to play a central role in angiogenesis, the disruption of VEGF-VEGF receptor system is a promising target for anti-cancer therapy. Previously, we reported that a hexapeptide (RRKRRR, RK6) blocked the growth and metastasis of tumor by inhibiting VEGF binding to its receptors. In addition, dRK6, the D-form derivative of RK6, retained its biological activity with improved serum stability. In the present study, we developed a serum-stable branched dimeric peptide (MAP2-dRK6) with enhanced anti-VEGF and anti-tumor activity. MAP2-dRK6 is more effective than dRK6 in many respects: inhibition of VEGF binding to its receptors, VEGF- and tumor conditioned medium-induced proliferation and ERK signaling of endothelial cells, and VEGF-induced migration and tube formation of endothelial cells. Moreover, MAP2-dRK6 blocks in vivo growth of VEGF-secreting colorectal cancer cells by the suppression of angiogenesis and the subsequent induction of tumor cell apoptosis. Our observations suggest that MAP2-dRK6 can be a prospective therapeutic molecule or lead compound for the development of drugs for various VEGF-related angiogenic diseases.

Keyword

angiogenesis inhibitors; colorectal neoplasms; peptides; receptors, vascular endothelial growth factor; vascular endothelial growth factors

MeSH Terms

Amino Acid Sequence
Angiogenesis Inhibitors/*pharmacology
Animals
Cell Movement/drug effects
Cell Proliferation/drug effects
Colorectal Neoplasms/*pathology/secretion
Endothelial Cells/cytology/drug effects/enzymology
Enzyme Activation/drug effects
Extracellular Signal-Regulated MAP Kinases/metabolism
Humans
Mice
Mice, Nude
Molecular Sequence Data
Neovascularization, Pathologic/pathology/prevention & control
Neovascularization, Physiologic/drug effects
Peptides/chemistry/*pharmacology
Protein Multimerization/*drug effects
Protein Stability/drug effects
Rats
Serum
Vascular Endothelial Growth Factor A/*antagonists & inhibitors/secretion
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr